CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 77 filers reported holding CADENCE PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 4.64 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FALCON POINT CAPITAL, LLC | 92,217 | $629,000 | 0.69% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 1,700,000 | $11,594,000 | 0.69% |
| NEA Management Company, LLC | 2,070,286 | $14,119,000 | 0.63% |
| WALL STREET ASSOCIATES | 460,000 | $3,137,000 | 0.32% |
| A.R.T. Advisors, LLC | 143,365 | $977,000 | 0.03% |
| PICTET ASSET MANAGEMENT LTD | 688,500 | $4,696,000 | 0.03% |
| Capital Research Global Investors | 6,398,173 | $43,636,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 6,334,921 | $43,204,000 | 0.01% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 14,770,282 | $100,734,000 | 0.01% |
| LORD, ABBETT & CO. LLC | 843,957 | $5,756,000 | 0.01% |